Balance Labs, Inc.
BLNC
$0.183
-$0.0095-4.94%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 47.30K | 46.80K | 46.10K | 45.70K | 13.50K |
| Gross Profit | -47.30K | -46.80K | -46.10K | -45.70K | -13.50K |
| SG&A Expenses | 16.70K | 36.90K | 11.70K | 20.00K | -9.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 64.00K | 83.70K | 57.90K | 65.70K | 4.40K |
| Operating Income | -64.00K | -83.70K | -57.90K | -65.70K | -4.40K |
| Income Before Tax | -117.70K | -192.80K | -100.70K | -116.90K | -128.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -117.70K | -192.80K | -100.70K | -116.90K | -128.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -117.70K | -192.80K | -100.70K | -116.90K | -128.80K |
| EBIT | -64.00K | -83.70K | -57.90K | -65.70K | -4.40K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 21.67M | 21.67M | 21.67M | 21.67M | 21.67M |
| Average Diluted Shares Outstanding | 21.67M | 21.67M | 21.67M | 21.67M | 21.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |